Dan Housman, BA

Dan is a seasoned entrepreneur in medicine with multiple successful exits. His background is in molecular biology and clinical informatics having founded Recombinant Data which was acquired by Deloitte Consulting in 2012. Dan founded his recent biotech venture Courage Therapeutics to focus on developing medicines for eating disorders after his daughter struggled with anorexia nervosa. He is a passionate advocate for patients and parents focused on leading to change through commercial investment to translate research into effective medicines.